Pharmacokinetics, Safety, and Tolerability of SYN-020

NCT04815993 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Theriva Biologics, Inc.

Collaborators